{"transactions":[{"id":746002,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-08T20:15:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":11580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11580},"source":{"system":"sec-edgar","filing":"0001280044-26-000004","document":"form4-06082026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000128004426000004/form4-06082026_040601.xml","form_type":"4"}},{"id":746001,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-08T20:15:06.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":10987,"derivative":{"underlying":"Common Stock","underlying_shares":10987},"source":{"system":"sec-edgar","filing":"0001280044-26-000004","document":"form4-06082026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000128004426000004/form4-06082026_040601.xml","form_type":"4"}},{"id":746000,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:15:06.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":42350,"derivative":{"exercise_price":4.71,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":42350},"source":{"system":"sec-edgar","filing":"0001280044-26-000004","document":"form4-06082026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000128004426000004/form4-06082026_040601.xml","form_type":"4"}},{"id":745999,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:15:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":11580,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":33334,"source":{"system":"sec-edgar","filing":"0001280044-26-000004","document":"form4-06082026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000128004426000004/form4-06082026_040601.xml","form_type":"4"}},{"id":767704,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-21T20:11:27.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":10539,"derivative":{"exercise_price":5.08,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":10539},"source":{"system":"sec-edgar","filing":"0001280044-26-000002","document":"form4-05212026_080523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000128004426000002/form4-05212026_080523.xml","form_type":"4"}},{"id":971014,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":13.06,"expiration_date":"2030-10-23","underlying":"Common Shares","underlying_shares":7957},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":971013,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":21.15,"expiration_date":"2031-05-28","underlying":"Common Shares","underlying_shares":12240},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":971012,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":18.56,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":16604},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":971011,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":23.29,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":971010,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":48.73,"expiration_date":"2034-05-07","underlying":"Common Shares","underlying_shares":8844},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":971009,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:49:20.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":41.6,"expiration_date":"2035-05-22","underlying":"Common Shares","underlying_shares":13193},"source":{"system":"sec-edgar","filing":"0001193125-25-317924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000119312525317924/ownership.xml","form_type":"4"}},{"id":1117685,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-09T20:20:16.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 6, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4793},"source":{"system":"sec-edgar","filing":"0001415889-25-016248","document":"form4-06092025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588925016248/form4-06092025_040604.xml","form_type":"4"}},{"id":1117684,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-09T20:20:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":11580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":11580,"derivative":{"underlying":"Common Stock","underlying_shares":11580},"source":{"system":"sec-edgar","filing":"0001415889-25-016248","document":"form4-06092025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588925016248/form4-06092025_040604.xml","form_type":"4"}},{"id":1117683,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:20:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":42350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":42350,"derivative":{"exercise_price":1.56,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":42350},"source":{"system":"sec-edgar","filing":"0001415889-25-016248","document":"form4-06092025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588925016248/form4-06092025_040604.xml","form_type":"4"}},{"id":1117682,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:20:16.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":21754,"source":{"system":"sec-edgar","filing":"0001415889-25-016248","document":"form4-06092025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588925016248/form4-06092025_040604.xml","form_type":"4"}},{"id":1129091,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-30T23:31:13.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":201857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":201857,"derivative":{"exercise_price":0.3598,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":201857},"source":{"system":"sec-edgar","filing":"0001415889-25-015059","document":"form4-05302025_110508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588925015059/form4-05302025_110508.xml","form_type":"4"}},{"id":1133232,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-05-27T12:00:08.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":13193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing on May 22, 2025 in 12 equal monthly installments."}],"balance_after":13193,"derivative":{"exercise_price":41.6,"expiration_date":"2035-05-22","underlying":"Common Shares","underlying_shares":13193},"source":{"system":"sec-edgar","filing":"0000950170-25-077382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000095017025077382/ownership.xml","form_type":"4"}},{"id":1484705,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-10T20:15:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":4793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."}],"balance_after":4793,"derivative":{"underlying":"Common Stock","underlying_shares":4793},"source":{"system":"sec-edgar","filing":"0001415889-24-016195","document":"form4-06102024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588924016195/form4-06102024_040609.xml","form_type":"4"}},{"id":1484704,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T20:15:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 6, 2024, subject to Reporting Person's continuous service through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."}],"balance_after":15750,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001415889-24-016195","document":"form4-06102024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588924016195/form4-06102024_040609.xml","form_type":"4"}},{"id":1491830,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-04T20:30:15.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001415889-24-015363","document":"form4-06042024_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588924015363/form4-06042024_040608.xml","form_type":"4"}},{"id":1491829,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:30:15.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":16961,"source":{"system":"sec-edgar","filing":"0001415889-24-015363","document":"form4-06042024_040608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588924015363/form4-06042024_040608.xml","form_type":"4"}},{"id":1503475,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-05-23T20:56:03.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":47693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2025 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":47693,"derivative":{"exercise_price":1.28,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":47693},"source":{"system":"sec-edgar","filing":"0001415889-24-014313","document":"form4-05232024_080547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000141588924014313/form4-05232024_080547.xml","form_type":"4"}},{"id":1522002,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-05-09T20:30:20.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 7, 2024 in 12 equal monthly installments."}],"balance_after":8844,"derivative":{"exercise_price":48.73,"expiration_date":"2034-05-07","underlying":"Common Shares","underlying_shares":8844},"source":{"system":"sec-edgar","filing":"0000950170-24-057081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000095017024057081/ownership.xml","form_type":"4"}},{"id":1810337,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T16:48:06.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":51,"price":0.51,"value":26.01,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares of common stock held in the name Brian Macdonald for Maxine Gowen Trust, for which the Reporting Person is a beneficiary and trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-012145","document":"form4-08112023_080800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588923012145/form4-08112023_080800.xml","form_type":"4"}},{"id":1858568,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2023-06-12T20:15:16.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing June 8, 2023 in 12 equal monthly installments."}],"balance_after":14414,"derivative":{"exercise_price":23.29,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0001209191-23-036267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123036267/doc4.xml","form_type":"4"}},{"id":1866668,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T21:04:19.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":false,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-23-034459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123034459/doc4.xml","form_type":"4"}},{"id":1866667,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T21:04:19.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":4660,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-23-034459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123034459/doc4.xml","form_type":"4"}},{"id":1866666,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T21:04:19.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 1, 2023, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":8.7,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-23-034459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123034459/doc4.xml","form_type":"4"}},{"id":1866665,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T21:04:19.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":true,"shares":4507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":12301,"source":{"system":"sec-edgar","filing":"0001209191-23-034459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123034459/doc4.xml","form_type":"4"}},{"id":1876222,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-05-26T20:24:16.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-23-032545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919123032545/doc4.xml","form_type":"4"}},{"id":2221600,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T16:31:14.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":0.4561,"exercise_date":"2023-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-22-006943","document":"form4-06272022_040647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922006943/form4-06272022_040647.xml","form_type":"4"}},{"id":2242092,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T21:15:31.000Z","date":"2022-06-03","kind":"exercise","acquired":false,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-22-034582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122034582/doc4.xml","form_type":"4"}},{"id":2242091,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T21:15:31.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."}],"balance_after":4507,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-22-034582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122034582/doc4.xml","form_type":"4"}},{"id":2242090,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T21:15:31.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":14.48,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-22-034582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122034582/doc4.xml","form_type":"4"}},{"id":2242089,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T21:15:31.000Z","date":"2022-06-03","kind":"exercise","acquired":true,"shares":3356,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":7794,"source":{"system":"sec-edgar","filing":"0001209191-22-034582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122034582/doc4.xml","form_type":"4"}},{"id":2247219,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2022-06-02T20:06:26.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":16604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 31, 2022 in 12 equal monthly installments."}],"balance_after":16604,"derivative":{"exercise_price":18.56,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":16604},"source":{"system":"sec-edgar","filing":"0000899243-22-020675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000089924322020675/doc4.xml","form_type":"4"}},{"id":2249327,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-01T20:27:52.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.8,"expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-033163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122033163/doc4.xml","form_type":"4"}},{"id":2251115,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-31T20:22:56.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1.76,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-032812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919122032812/doc4.xml","form_type":"4"}},{"id":2666005,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2021-06-16T20:05:20.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":12240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest as to 33% on May 28, 2022 and as to 1/24th monthly thereafter, subject to the non-executive director continuing in service as a non-executive director through each such vesting date."}],"balance_after":12240,"derivative":{"exercise_price":21.15,"expiration_date":"2031-05-28","underlying":"Common Shares","underlying_shares":12240},"source":{"system":"sec-edgar","filing":"0000899243-21-024126","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000089924321024126/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-02"}},{"id":2674658,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:25:21.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2021 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 8, 2022 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":1.31,"exercise_date":"2022-06-08","expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-21-002922","document":"form4-06102021_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921002922/form4-06102021_050601.xml","form_type":"4"}},{"id":2680730,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-04T23:55:43.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."}],"balance_after":3356,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-21-038444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919121038444/doc4.xml","form_type":"4"}},{"id":2680729,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T23:55:43.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date."}],"balance_after":12250,"derivative":{"exercise_price":21.9,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001209191-21-038444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919121038444/doc4.xml","form_type":"4"}},{"id":2686139,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2021-06-02T20:10:46.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":12240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 28, 2021 in 12 equal monthly installments."}],"balance_after":12240,"derivative":{"exercise_price":21.15,"expiration_date":"2031-05-28","underlying":"Common Shares","underlying_shares":12240},"source":{"system":"sec-edgar","filing":"0000899243-21-021549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000089924321021549/doc4.xml","form_type":"4"}},{"id":2688741,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-01T17:51:55.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":4542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/12 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":4542,"derivative":{"exercise_price":13.83,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":4542},"source":{"system":"sec-edgar","filing":"0001209191-21-036754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919121036754/doc4.xml","form_type":"4"}},{"id":2842979,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-22T22:45:40.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":33836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on March 18, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":33836,"derivative":{"exercise_price":21.46,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":33836},"source":{"system":"sec-edgar","filing":"0001209191-21-012828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919121012828/doc4.xml","form_type":"4"}},{"id":3116071,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-09T20:17:35.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":11.96,"exercise_date":"2021-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-20-004358","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218020004358/primarydocument.xml","form_type":"4"}},{"id":3116070,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:17:35.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":4567,"price":12.05,"value":55032.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019."}],"balance_after":24133,"source":{"system":"sec-edgar","filing":"0001562180-20-004358","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218020004358/primarydocument.xml","form_type":"4"}},{"id":3116069,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:17:35.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":28700,"source":{"system":"sec-edgar","filing":"0001562180-20-004358","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218020004358/primarydocument.xml","form_type":"4"}},{"id":3118437,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Grant (right to buy)","published_at":"2020-06-08T21:45:51.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 4, 2020, subject to Reporting Person's continuous service through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.41,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-20-035056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919120035056/doc4.xml","form_type":"4"}},{"id":3143938,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T19:07:36.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2020 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on May 12, 2021 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":1.97,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-20-006349","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020006349/edgar.xml","form_type":"4"}},{"id":3147092,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T21:22:59.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":64103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":64103,"derivative":{"exercise_price":1.05,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":64103},"source":{"system":"sec-edgar","filing":"0001209191-20-029773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919120029773/doc4.xml","form_type":"4"}},{"id":3227047,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T21:23:47.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4438},"source":{"system":"sec-edgar","filing":"0001209191-20-016076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919120016076/doc4.xml","form_type":"4"}},{"id":3227046,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T21:23:47.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":4438,"derivative":{"underlying":"Common Stock","underlying_shares":4438},"source":{"system":"sec-edgar","filing":"0001209191-20-016076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919120016076/doc4.xml","form_type":"4"}},{"id":3227045,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T21:23:47.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":4438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":4438,"source":{"system":"sec-edgar","filing":"0001209191-20-016076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919120016076/doc4.xml","form_type":"4"}},{"id":3467699,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-07-03T20:47:28.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option will vest in thirty-six (36) equal monthly installments commencing on the one-month anniversary of July 2, 2019, subject to the reporting person's continuous service through each vesting date."}],"balance_after":16000,"derivative":{"exercise_price":2.34,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-19-041175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000120919119041175/doc4.xml","form_type":"4"}},{"id":3495535,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-10T20:04:20.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":4.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-19-003436","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218019003436/primarydocument.xml","form_type":"4"}},{"id":3495534,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T20:04:20.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\").  100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001562180-19-003436","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218019003436/primarydocument.xml","form_type":"4"}},{"id":3499501,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:06:00.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2019 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 4, 2020 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":2.57,"exercise_date":"2020-06-04","expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-19-007278","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019007278/edgar.xml","form_type":"4"}},{"id":3523710,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:31:25.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.34,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-030520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919119030520/doc4.xml","form_type":"4"}},{"id":3674268,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T21:59:01.000Z","date":"2019-02-01","kind":"purchase","acquired":true,"shares":50000,"price":1.02,"value":51000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.01 - $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"50,000 of these shares are held jointly with the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by her spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of her spouse's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001209191-19-007388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919119007388/doc4.xml","form_type":"4"}},{"id":3885633,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-22T16:01:01.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":50000,"price":1.53,"value":76500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted pursuant to the Company's director compensation on the date of the Company's 2018 annual meeting of stockholders at an exercise price to the closing price of the Company's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options will vest in full and become immediately exercisable on the first anniversary of the date of grant, subject to continued service as director, and are granted under the Company's 2013 Stock Incentive Plan, as amended."}],"balance_after":50000,"derivative":{"exercise_price":1.53,"exercise_date":"2019-06-20","expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-18-008941","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018008941/edgar.xml","form_type":"4"}},{"id":3892286,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-06-15T12:16:49.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an option to purchase shares of Akebia Therapeutics, Inc.'s (the \"Company's\") common stock granted by the Company pursuant to the Company's 2014 Incentive Plan (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company."}],"balance_after":12500,"derivative":{"exercise_price":11.14,"exercise_date":"2019-06-14","expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-003016","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218018003016/primarydocument.xml","form_type":"4"}},{"id":4019761,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-02T22:20:43.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":252500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on an annual basis (every twelve months) from the Transaction Date listed above, with respect to one-half of the total number of shares subject to the option, in each case subject to the reporting person's Continuous Service (as defined in the 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":252500,"derivative":{"exercise_price":1.79,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":252500},"source":{"system":"sec-edgar","filing":"0001209191-18-015840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919118015840/doc4.xml","form_type":"4"}},{"id":4019760,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-02T22:20:43.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-sixteenth of the total number of shares subject to the option on a quarterly basis (every three months) from the Transaction Date listed above, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-015840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919118015840/doc4.xml","form_type":"4"}},{"id":4222498,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-08-29T20:43:34.000Z","date":"2017-08-28","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-sixteenth of the total number of shares subject to the option on a quarterly basis (every three months) from the Transaction Date listed above, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.37,"expiration_date":"2027-08-28","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-17-050602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117050602/doc4.xml","form_type":"4"}},{"id":4277296,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-06-19T20:04:48.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option shares vest on the first anniversary of the date of grant (the \"Vesting Date\"), provided that the Reporting Person remains in continuous service as a member of the Issuer's Board of Directors through the Vesting Date, and provided further that the options held by the Reporting Person shall be eligible for vesting acceleration upon a \"Change in Control\" as defined and provided for in the Issuer's Non-Employee Director Stock Option Award Agreement."}],"balance_after":12500,"derivative":{"exercise_price":14.37,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-17-002291","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280044/000156218017002291/primarydocument.xml","form_type":"4"}},{"id":4287040,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-05-25","kind":"gift","acquired":true,"shares":403,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the Brian MacDonald Irrevocable Trust. The reporting person's spouse is the beneficiary and the Trustee of the Brian MacDonald Irrevocable Trust. The reporting person disclaims beneficial ownership of the shares held by the Brian MacDonald Irrevocable Trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of her children's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":195512,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287039,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-05-25","kind":"gift","acquired":false,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287038,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-03-16","kind":"gift","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Maxine Gowen Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Maxine Gowen Irrevocable Trust. The reporting person is the beneficiary and the Trustee of the Maxine Gowen Irrevocable Trust."}],"balance_after":216500,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287037,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-03-16","kind":"gift","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Maxine Gowen Irrevocable Trust."}],"balance_after":4403,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287036,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-03-13","kind":"gift","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the Brian MacDonald Irrevocable Trust. The reporting person's spouse is the beneficiary and the Trustee of the Brian MacDonald Irrevocable Trust. The reporting person disclaims beneficial ownership of the shares held by the Brian MacDonald Irrevocable Trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of her children's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":195109,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287035,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-03-13","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."}],"balance_after":64403,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287034,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-23","kind":"gift","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the Brian MacDonald Irrevocable Trust. The reporting person's spouse is the beneficiary and the Trustee of the Brian MacDonald Irrevocable Trust. The reporting person disclaims beneficial ownership of the shares held by the Brian MacDonald Irrevocable Trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of her children's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":145109,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287033,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-23","kind":"gift","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."}],"balance_after":114403,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287032,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-23","kind":"gift","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Maxine Gowen Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Maxine Gowen Irrevocable Trust. The reporting person is the beneficiary and the Trustee of the Maxine Gowen Irrevocable Trust."}],"balance_after":156500,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287031,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-23","kind":"gift","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Maxine Gowen Irrevocable Trust."}],"balance_after":120403,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287030,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-06","kind":"gift","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person's spouse to the Maxine Gowen Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Maxine Gowen Irrevocable Trust. The reporting person is the beneficiary and the Trustee of the Maxine Gowen Irrevocable Trust."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287029,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-09T21:57:16.000Z","date":"2017-01-06","kind":"gift","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person's spouse to the Maxine Gowen Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by her spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of her spouse's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-17-038965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038965/doc4.xml","form_type":"4"}},{"id":4287753,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-09T16:16:16.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted pursuant to the Company's director compensation on the date of the Company's 2017 annual meeting of stockholders at an exercise price to the closing price of the Company's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options will vest in full and become immediately exercisable on the first anniversary of the date of grant, subject to continued service as director, and are granted under the Company's 2013 Stock Incentive Plan, as amended."}],"balance_after":50000,"derivative":{"exercise_price":1.63,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-17-008810","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911017008810/edgar.xml","form_type":"4"}},{"id":4287749,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T16:15:01.000Z","date":"2016-10-16","kind":"gift","acquired":true,"shares":10542,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1,"source":{"system":"sec-edgar","filing":"0001179110-17-008807","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911017008807/edgar.xml","form_type":"5"}},{"id":4403691,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T21:56:55.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":303000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":303000,"derivative":{"exercise_price":4.13,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":303000},"source":{"system":"sec-edgar","filing":"0001209191-17-017687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117017687/doc4.xml","form_type":"4"}},{"id":4421263,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-27T13:34:02.000Z","date":"2017-02-23","kind":"exercise","acquired":false,"shares":106329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.682,"expiration_date":"2020-09-10","underlying":"Common Stock","underlying_shares":106329},"source":{"system":"sec-edgar","filing":"0001209191-17-014568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117014568/doc4.xml","form_type":"4"}},{"id":4421262,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-27T13:34:02.000Z","date":"2017-02-23","kind":"exercise","acquired":false,"shares":4074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.682,"expiration_date":"2021-06-23","underlying":"Common Stock","underlying_shares":4074},"source":{"system":"sec-edgar","filing":"0001209191-17-014568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117014568/doc4.xml","form_type":"4"}},{"id":4421261,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-02-27T13:34:02.000Z","date":"2017-02-23","kind":"exercise","acquired":true,"shares":110403,"price":0.682,"value":75294.846,"ownership":{"direct":true},"balance_after":126903,"source":{"system":"sec-edgar","filing":"0001209191-17-014568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117014568/doc4.xml","form_type":"4"}},{"id":4496288,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-06T21:42:53.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of January 6, 2018, January 6, 2019, January 6, 2020 and January 6, 2021, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date."}],"balance_after":175000,"derivative":{"exercise_price":6.61,"expiration_date":"2027-01-06","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-17-002668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117002668/doc4.xml","form_type":"4"}},{"id":4500114,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T16:29:11.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":7000,"price":1.5,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This stock was issued to the reporting person pursuant to her election under the Issuer's director compensation program in lieu of cash."}],"balance_after":17543,"source":{"system":"sec-edgar","filing":"0001179110-17-000514","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911017000514/edgar.xml","form_type":"4"}},{"id":4562040,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-11-09T22:37:47.000Z","date":"2016-11-07","kind":"purchase","acquired":true,"shares":12500,"price":4.1,"value":51250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 - $4.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001209191-16-149122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116149122/doc4.xml","form_type":"4"}},{"id":4574796,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-25T21:28:30.000Z","date":"2016-10-20","kind":"gift","acquired":true,"shares":4084,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by the Brian MacDonald Irrevocable Trust. The reporting person's spouse is the beneficiary and the Trustee of the Brian MacDonald Irrevocable Trust. The reporting person disclaims beneficial ownership of the shares held by the Brian MacDonald Irrevocable Trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of her children's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":139109,"source":{"system":"sec-edgar","filing":"0001209191-16-146893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146893/doc4.xml","form_type":"4"}},{"id":4574795,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-25T21:28:30.000Z","date":"2016-10-20","kind":"gift","acquired":false,"shares":4084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-16-146893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146893/doc4.xml","form_type":"4"}},{"id":4574794,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-25T21:28:30.000Z","date":"2016-10-20","kind":"gift","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by her spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of her spouse's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":154000,"source":{"system":"sec-edgar","filing":"0001209191-16-146893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146893/doc4.xml","form_type":"4"}},{"id":4574793,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-25T21:28:30.000Z","date":"2016-10-20","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."}],"balance_after":8084,"source":{"system":"sec-edgar","filing":"0001209191-16-146893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146893/doc4.xml","form_type":"4"}},{"id":4577545,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-10-17","kind":"gift","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by her spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of her spouse's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4577544,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-10-17","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."}],"balance_after":18084,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4577543,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-10-17","kind":"gift","acquired":true,"shares":135025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by the Brian MacDonald Irrevocable Trust. The reporting person's spouse is the beneficiary and the Trustee of the Brian MacDonald Irrevocable Trust. The reporting person disclaims beneficial ownership of the shares held by the Brian MacDonald Irrevocable Trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of her children's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":135025,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4577542,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-10-17","kind":"gift","acquired":false,"shares":135025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to  the Brian MacDonald Irrevocable Trust."}],"balance_after":28084,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4577541,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-09-29","kind":"gift","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by her spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of her spouse's shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":134000,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4577540,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-19T20:43:43.000Z","date":"2016-09-29","kind":"gift","acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to her spouse."}],"balance_after":163109,"source":{"system":"sec-edgar","filing":"0001209191-16-146367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919116146367/doc4.xml","form_type":"4"}},{"id":4585350,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":40436,"kind":"person","name":"GOWEN MAXINE","position":1,"cik":"0001280044","reported_name":"GOWEN MAXINE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T16:52:41.000Z","date":"2016-10-03","kind":"purchase","acquired":true,"shares":4102,"price":2.56,"value":10501.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This stock was issued to the reporting person pursuant to her election under the Issuer's director compensation program in lieu of cash."}],"balance_after":10543,"source":{"system":"sec-edgar","filing":"0001179110-16-030454","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911016030454/edgar.xml","form_type":"4"}}]}